Cargando…
Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy
Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive disease caused by human T-cell lymphotropic virus type 1 that predominantly affects Japanese and Caribbean populations. Most studies have focused on Japanese cohorts. We conducted a retrospective analysis of 53 cases of ATLL who presente...
Autores principales: | Zell, Monica, Assal, Amer, Derman, Olga, Kornblum, Noah, Battini, Ramakrishna, Wang, Yanhua, Narasimhulu, Deepa M., Mantzaris, Ioannis, Shastri, Aditi, Verma, Amit, Ye, Hilda, Braunschweig, Ira, Janakiram, Murali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239529/ https://www.ncbi.nlm.nih.gov/pubmed/27341021 http://dx.doi.org/10.18632/oncotarget.10223 |
Ejemplares similares
-
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
por: Liu, Kenneth G., et al.
Publicado: (2016) -
Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018) -
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
por: Abbasi, Ahmed, et al.
Publicado: (2020) -
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort
por: Rabinovich, Emma, et al.
Publicado: (2021) -
Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
por: Jasra, Sakshi, et al.
Publicado: (2021)